Stewart Bennett

Global Head of Alternatives, BMO Global Asset Management

Stewart Bennett joined the business in May 2019 as Global Head of Alternatives. Stewart oversees BMO Global Asset Management’s newly formed Global Alternatives offering, incorporating its existing private equity, real estate and real estate securities businesses, which will provide investors with a broader range of innovative real asset investment solutions.

Stewart is responsible for developing and executing BMO Global Asset Management’s alternative investments global growth strategy, building on the track record of delivering superior risk-adjusted returns by effectively leveraging synergies across the three businesses and significantly expanding its reach globally.

Stewart joined BMO Global Asset Management with 25 years of experience in investment banking and private equity, including 10 years as a partner and Head of the Financial Institutions Group (FIG) at Ondra Partners, the London based independent investment banking firm. His previous experience includes Dresdner Kleinwort, where he was Managing Director and Head of FIG, Strategic Advisory, and the private equity firm Botts & Company.

Related Articles

No posts matching your criteria

The ESG implications of COVID-19: Annual General Meetings (AGMs)

Discover how COVID-19 has pushed AGMs around the world into an online format.

The ESG implications of COVID-19: Executive Pay

Explore the executive pay implications of COVID-19 at top UK companies

Is the market due for a fall?

Macro Update 19 October 2020

BMO SDG Engagement Global Equity Strategy Impact Report 2020

In this report, we carry out a deep dive into our engagement activities, showing the alignment to the SDGs and their targets.

September 2020

The Fed’s new framework and its evolving reaction function

For investors, the implications are likely to be a more durable long-run “risk on” environment, a flatter yield curve and a depreciating dollar.

September 2020

Back to the future of fixed income

Enough bizarre outcomes have materialized in 2020, that many people just respond, “It’s 2020!?”

Will the vaccine save Christmas?

Macro Update 28 September 2020

ESG Viewpoint – COVID-19 and the pharmaceutical industry

How is the pharmaceutical industry responding to COVID-19?

VIEW MORE